XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,911,081 | -11.2% | 55,945 | +0.1% | 0.00% | – |
Q2 2023 | $2,152,727 | +7.9% | 55,915 | +0.3% | 0.00% | – |
Q1 2023 | $1,994,397 | +91428.1% | 55,725 | +0.8% | 0.00% | – |
Q4 2022 | $2,179 | -99.9% | 55,285 | -10.6% | 0.00% | – |
Q3 2022 | $2,231,000 | +61.2% | 61,823 | +35.8% | 0.00% | – |
Q2 2022 | $1,384,000 | +60.6% | 45,516 | +61.4% | 0.00% | – |
Q1 2022 | $862,000 | -2.0% | 28,198 | 0.0% | 0.00% | – |
Q4 2021 | $880,000 | +166.7% | 28,198 | +30.2% | 0.00% | – |
Q3 2021 | $330,000 | -18.1% | 21,650 | 0.0% | 0.00% | – |
Q2 2021 | $403,000 | +17.2% | 21,650 | +12.5% | 0.00% | – |
Q1 2021 | $344,000 | +16.6% | 19,242 | 0.0% | 0.00% | – |
Q4 2020 | $295,000 | +38.5% | 19,242 | 0.0% | 0.00% | – |
Q3 2020 | $213,000 | -11.6% | 19,242 | 0.0% | 0.00% | – |
Q2 2020 | $241,000 | +10.6% | 19,242 | 0.0% | 0.00% | – |
Q1 2020 | $218,000 | -56.7% | 19,242 | -50.0% | 0.00% | – |
Q4 2019 | $504,000 | +191.3% | 38,484 | +100.0% | 0.00% | – |
Q3 2019 | $173,000 | -8.5% | 19,242 | 0.0% | 0.00% | – |
Q2 2019 | $189,000 | +32.2% | 19,242 | +36.6% | 0.00% | – |
Q1 2019 | $143,000 | -18.8% | 14,084 | -50.0% | 0.00% | – |
Q4 2018 | $176,000 | +329.3% | 28,168 | +171.2% | 0.00% | – |
Q1 2017 | $41,000 | -46.8% | 10,386 | +3.7% | 0.00% | – |
Q4 2016 | $77,000 | – | 10,020 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |